SR1824 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Peroxisome proliferator-activated receptor γ (PPARγ) is activated by the anti-diabetes drugs known as thiazolidinediones, including rosiglitazone and pioglitazone . Phosphorylation of PPARγ by cyclin-dependent kinase 5 (Cdk5) causes dysregulation of genes whose expression is altered in obesity, including adiponectin. SR 1824 is a non-agonist PPARγ ligand (K_i = 10 nM) which blocks Cdk5-mediated phosphorylation. It does not inhibit activation of PPARγ by rosiglitazone .

Verwenden

SR 1824 is a non-agonist Peroxisome proliferator-activated receptor γ (PPARγ) ligand.

SR1824 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

SR1824 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ChemeGen(Shanghai) Biotechnology Co.,Ltd.	18818260767	sales@chemegen.com	China	11218	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44807	58
MedBioPharmaceutical Technology Inc	021-69568360 18916172912	order@med-bio.cn	China	8140	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
United States Biological	--	sales@advtechind.com	United States	6075	58
ApexBio Technology	--	sales@apexbt.com	United States	6251	58

---

• SR1824
• HBMXDCXJXYASGW-NRFANRHFSA-N
• [1,1'-Biphenyl]-2-carboxylic acid, 4'-[[5-[[[(1S)-1-(4-bromophenyl)ethyl]amino]carbonyl]-2,3-dimethyl-1H-indol-1-yl]methyl]-
• 1338259-06-5
• C33H29BrN2O3